Emerging 2026 Research Is Pointing to a New Root Cause of Heart Attacks That Run in Families — and What Can Finally Be Done About It
I've been treating people who watched a parent's heart give out for twenty years. For most of those twenty years, the field didn't have a clear answer for why it kept coming for them.
That's changed.
Over the last several years, a body of research has been building across cardiology, blood-clotting, and nutrition journals — and in 2026, what was once a fringe hypothesis is becoming the broadly accepted explanation: the plaque that runs in your family is, at its core, a condition of the fibrin it's built on.
You don't need to take my word for it. Open a new tab and type "fibrin and artery plaque" into Google. Look at what comes up.
Medical journals. Research universities. Clinical reviews. This isn't fringe. It's where the science has landed.
Here's what that actually means.
What Fibrin Is
Right inside your artery walls, there's a sticky protein your blood lays down called fibrin. Think of it as a mesh of wet spider silk, but alive, and woven into every artery, every vessel, and every tiny tear in your body, holding every repair in place.
When you're young and your blood is healthy, it's laid down and dissolved the same day. Your blood rushes past it without friction. You don't feel it. It does its job invisibly.
But your arteries need their own clot-dissolving enzymes to stay that way — the cleaners they use to break the mesh down, keep the wall smooth, and keep cholesterol from getting caught in it.
As you age, that clean-up slows down. Your body produces less of what dissolves fibrin. Your genes, stress, fried food, and accumulated wear speed the process up. The mesh stops getting cleared.
So it piles up.
Uncleared fibrin loses its thin, temporary quality. It thickens. It hardens. And as it hardens, it begins to physically trap everything floating past it — including the cholesterol and calcium that turn it into plaque.
And once you understand that mechanism, every symptom you've been carrying makes sense.
Doing everything right, and nothing moving
Fibrin lines your artery walls from your neck to your heart. When the mesh thickens across that many arteries at once, the plaque keeps growing whether you ran this morning or not — because the entire system is still catching.
The calcium score that scared you
The fibrin in the arteries wrapping your heart is the frame calcium settles into. When it hardens, the scan lights up white.
Feeling fine with a time-bomb inside
When fibrin thickens behind the artery lining, nothing hurts — the channel just narrows in silence. You feel great on the treadmill because the mesh is being built up before a single warning sign even reaches you.
Doing the math at 2am
When the mesh is thick, every heartbeat pushes harder than it should. By 2am, you're awake counting the years to your father's age — not because you're paranoid, but because your heart has been pushing against resistance from the inside.
The Research Behind It
This isn't a single study or a fringe theory. It's a converging body of work across multiple labs and journals:
A parent with early heart disease roughly doubles your own risk — even after cholesterol, blood pressure, and smoking are counted.
In 31 studies of 154,211 people, the more fibrinogen in the blood, the more heart attacks and strokes.
Of 29,079 Japanese adults followed for 16 years, the biggest natto eaters had 25% fewer deaths from heart disease and stroke.
10,800 FU of nattokinase daily for a year shrank carotid plaque and artery-wall thickness in 1,062 people.
These are a few papers out of dozens. All peer-reviewed, all in PubMed, all published in major medical journals.
The 2022 study is the most recent — and it confirms, in 1,062 people, that nattokinase shrinks the plaque already sitting in the artery wall.
The findings are public. They've just been slow to reach clinical practice.
Why Nothing You've Tried Has Worked
Statins, red yeast rice, fish oil — every pill you've been handed for the heart disease in your family is designed to do the same thing: lower the number on your lab sheet.
None of them touch the reason the plaque is building in the first place. The fibrin mesh is still there, still catching everything that floats past it, still hardening the plaque your number says you're safe from.
That's why the scan never gets better. Nothing in your medicine cabinet was ever pointed at the fibrin.
What Clearing The Fibrin Actually Requires
It's the same mechanism, in reverse.
Your arteries filled up because your body stopped making enough of what dissolves fibrin. Give that back, and the mesh dissolves. As it dissolves, the plaque loses its frame. As it loses its frame, the artery releases its grip on what it's been trapping — and the creeping numbers, the scan, and the 2am dread start to resolve at the source.
There's no shortcut around this. You can't lower the number far enough, or eat clean long enough, to fix a problem that lives inside the artery wall. The wall has to be cleared from the inside, with the enzyme it lost.
I spent years recommending the closest things I could find — red yeast rice, fish oil, cheap nattokinase off Amazon. I kept coming back to the same conclusion: the ingredients existed, but nothing was putting them together correctly.
So in early 2025, I decided to build the formulation myself.
I teamed up with a small group of cardiology and blood-clotting researchers, and we spent the better part of a year working through the literature, sourcing the right forms of each ingredient, and testing the formulation. By the end of 2025, we had it.
Noverly Nattokinase
The formulation centers on three core actives — chosen because they're each in the form that actually reaches the artery wall.
They're supported by CoQ10, turmeric, aged garlic, pine bark, grape seed, and dandelion root — a matrix that helps the actives absorb and reach the artery wall.
Every ingredient is research-backed. Every dose is based on what the peer-reviewed literature supports. Nothing is in there for marketing — no under-dosed enzyme, no fillers, no ingredients that look impressive on a label but don't reach the artery wall.
What Happened With The First 1,000 Customers
In early 2026 we ran an initial launch and tracked outcomes from our first 1,000 customers across the first 90 days on the protocol. Among those who completed the full 90 days:
These aren't clinical trial numbers. They're self-reported outcomes from real customers — most of whom had watched a parent's heart give out and had already tried everything else.
Most reported the shift starting between week three and week six. By day 90, the majority were describing it the same way: not a number that had been managed, but an artery that was finally being cleared.
If you've been carrying your family's heart history long enough to know that lowering the number isn't the same as clearing the artery, Noverly is built for what you've actually been looking for.
Try it for 90 days.
If it doesn't work for you in that window, send it back. Full refund. No questions, no fine print, no return process designed to wear you down. I don't want patients paying for something that isn't helping them.